3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
2
Phase 1/2
2
Phase 1
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Plasma cell
2
Conditions
Multiple Myeloma
2
Recurrence
1
Disease Progression
1
Interventions
Dexamethasone
129
Lenalidomide
70
Cyclophosphamide
70
Bortezomib
69
Calcium Dobesilate
50
fludarabine
44
pomalidomide
40
daratumumab
37
carfilzomib
33
fludarabine phosphate
31
Melphalan
25
dexamethasone acetate
20
dexamethasone 21-phosphate
20
auricularum
18
Filgrastim
18
Whole-Body Irradiation
14
Biopsy
13
isatuximab
12
Vorinostat
12
Tacrolimus
12
Peripheral Blood Stem Cell Transplantation
12
Magnetic Resonance Spectroscopy
12
Granulocyte Colony-Stimulating Factor
12
Specimen Handling
11
Sirolimus
11
ixazomib
10
belantamab mafodotin
10
Panobinostat
10
Mycophenolic Acid
10
Cyclosporine
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Multiple Myeloma
×
Transplantation, Autologous
×
Clear all
NCT02043847
2024-11-13
BMT-03
University of Illinois at Chicago
Phase 1
Completed
12 enrolled
12 charts
NCT02043860
2019-10-14
BMT-02
University of Illinois at Chicago
Phase 1
Terminated
3 enrolled
5 charts